Cargando…

Statin intensity and risk for cardiovascular events after heart transplantation

AIMS: Statins improve survival and reduce rejection and cardiac allograft vasculopathy after heart transplantation (HT). The impact of different statin intensities on clinical outcomes has never been assessed. We set out to determine the impact of statin exposure on cardiovascular outcomes after HT....

Descripción completa

Detalles Bibliográficos
Autores principales:	Golbus, Jessica R., Adie, Sarah, Yosef, Matheos, Murthy, Venkatesh L., Aaronson, Keith D., Konerman, Matthew C.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2020
Materias:	Original Research Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7524051/ https://www.ncbi.nlm.nih.gov/pubmed/32578953 http://dx.doi.org/10.1002/ehf2.12784

Ejemplares similares

Utility of routine evaluations for rejection in patients greater than 2 years after heart transplantation
por: Golbus, Jessica R., et al.
Publicado: (2020)

TRENDS IN CANDIDATE TRANSPLANT STATUS FOR SINGLE ORGAN HEART TRANSPLANTS DURING THE COVID-19 PANDEMIC
por: Gupta, Kashvi, et al.
Publicado: (2021)

Coronavirus Disease-2019 in Heart Transplant Recipients in Southeastern Michigan: A Case Series
por: Ketcham, Scott W., et al.
Publicado: (2020)

Short‐term outcomes after sodium‐glucose cotransporter‐2 inhibitor initiation in a cohort of heart failure patients
por: Pérez Martínez, Bryan O., et al.
Publicado: (2023)

Predicting need for heart failure advanced therapies using an interpretable tropical geometry-based fuzzy neural network
por: Zhang, Yufeng, et al.
Publicado: (2023)

Statin use and incident cardiovascular events in renal transplant recipients
por: Anderson, Josephine L. C., et al.
Publicado: (2021)

The role of statins in patients after heart transplantation
por: Szyguła-Jurkiewicz, Bożena, et al.
Publicado: (2015)

Risk of mortality and recurrent cardiovascular events in patients with acute coronary syndromes on high intensity statin treatment
por: Rockberg, J., et al.
Publicado: (2017)

Preoperative clinical diagnostic accuracy of heart failure among patients undergoing major noncardiac surgery: a single-centre prospective observational analysis
por: Golbus, Jessica R., et al.
Publicado: (2022)

Loss‐Framed Financial Incentives With a Wearable Device for Secondary Prevention of Ischemic Heart Disease: Stepping Up to the Challenge?
por: Golbus, Jessica R., et al.
Publicado: (2018)

Statin Discontinuation and Cardiovascular Events Among Older People in Denmark
por: Thompson, Wade, et al.
Publicado: (2021)

Comparison of the Effects of High-intensity Statin Therapy with Moderate-Intensity Statin and Ezetimibe Combination Therapy on Major Adverse Cardiovascular Events in Patients with Acute Myocardial Infarction: a Nationwide Cohort Study
por: Kim, Kihyun, et al.
Publicado: (2021)

Association Between Statin Use and Cardiovascular Events After Carotid Artery Revascularization
por: Hussain, Mohamad A., et al.
Publicado: (2018)

Hoping rosuvastatin for primary prevention of cardiovascular events, are all statins similar and are we ready for statinizing the globe?
por: Kumar, Arun H. S.
Publicado: (2016)

Efficacy of Standard and Intensive Statin Treatment for the Secondary Prevention of Cardiovascular and Cerebrovascular Events in Diabetes Patients: A Meta-Analysis
por: de Vries, Folgerdiena M., et al.
Publicado: (2014)

New onset diabetes mellitus and cardiovascular events in Korean patients with acute myocardial infarction receiving high-intensity statins
por: Choi, Jah Yeon, et al.
Publicado: (2021)

Wildfire smoke exposure and cardiovascular disease—should statins be recommended to prevent cardiovascular events?
por: Vuorio, Alpo, et al.
Publicado: (2023)

Statin therapy for preventing cardiovascular diseases in patients treated with tacrolimus after kidney transplantation
por: Han, Nayoung, et al.
Publicado: (2017)

Mobile Health Technology: (Smart)Watch and Wait
por: Golbus, Jessica R.
Publicado: (2023)

Association of Statin and Its Lipophilicity With Cardiovascular Events in Patients Receiving Chronic Dialysis
por: Wang, Shih‐Wei, et al.
Publicado: (2019)

Atherosclerotic Cardiovascular Disease Events in Adults With CKD Taking a Moderate- or High-Intensity Statin: The Chronic Renal Insufficiency Cohort (CRIC) Study
por: Poudel, Bharat, et al.
Publicado: (2021)

The JUPITER study: statins for the primary prevention of cardiovascular events in patients with inflammatory rheumatic diseases?
por: Ward, Michael M
Publicado: (2009)

Genome Wide Epistasis Study of On-Statin Cardiovascular Events with Iterative Feature Reduction and Selection
por: Adams, Solomon M., et al.
Publicado: (2020)

Cardiovascular Events in Patients Received Combined Fibrate/Statin Treatment versus Statin Monotherapy: Acute Coronary Syndrome Israeli Surveys Data
por: Tenenbaum, Alexander, et al.
Publicado: (2012)

Effect and safety of combination lipid‐lowering therapies based on statin treatment versus statin monotherapies on patients with high risk of cardiovascular events
por: Wang, Chunli, et al.
Publicado: (2018)

Similar major cardiovascular outcomes between pure statin and ezetimibe-statin in comparable intensity for type 2 diabetes with extremely atherosclerotic risks
por: Kao, Yu-Cheng, et al.
Publicado: (2021)

Statins; the panacea of cardiovascular disease
por: de Waard, G. A., et al.
Publicado: (2017)

Impact of statin intensity on adverse cardiac and cerebrovascular events in older adult patients with myocardial infarction
por: Moon, In Tae, et al.
Publicado: (2021)

Intensity of statin therapy and new hospitalizations for heart failure in patients with type 2 diabetes
por: Kishimoto, Ichiro, et al.
Publicado: (2015)

STATIN USE AT TIME OF RESPIRATORY VIRAL INFECTION IN PATIENTS WITH PRIOR HISTORY OF CARDIOVASCULAR DISEASE AND RISK OF SUBSEQUENT CARDIOVASCULAR EVENTS
por: Knight, Stacey, et al.
Publicado: (2015)

Underuse of statins for secondary prevention of atherosclerotic cardiovascular disease events among ambulatory surgical patients
por: Schonberger, Robert B., et al.
Publicado: (2020)

Optimal target of LDL cholesterol level for statin treatment: challenges to monotonic relationship with cardiovascular events
por: Sakuma, Masashi, et al.
Publicado: (2022)

Cardiovascular events more than 6 months after pregnancy in patients with congenital heart disease
por: Schultz, Hayley, et al.
Publicado: (2023)

Cardiovascular health in pediatric heart transplant patients
por: Bogle, Carmel, et al.
Publicado: (2022)

Prediction of Cardiovascular Disease Risk Accounting for Future Initiation of Statin Treatment
por: Xu, Zhe, et al.
Publicado: (2021)

Prevalence and Predictors of Early Cardiovascular Events after Kidney Transplantation: Evaluation of Pre-Transplant Cardiovascular Work-Up
por: Delville, Marianne, et al.
Publicado: (2015)

Assessing Muscle-Related Adverse Events in Randomized Trials of Statins
por: Doshi, Peter, et al.
Publicado: (2022)

Statins for primary cardiovascular prevention in the elderly
por: Pedro-Botet, Juan, et al.
Publicado: (2015)

Non-cardiovascular effects associated with statins
por: Desai, Chintan S, et al.
Publicado: (2014)

Incidence of cardiovascular events after kidney transplantation and cardiovascular risk scores: study protocol
por: Pita-Fernández, Salvador, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_4odqpps9u52nh64k5ugehfae42